◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

HLS Therapeutics Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 56.6M 63.1M 61.5M 60.0M
Operating Revenue 56.6M 63.1M 61.5M 60.0M
Cost Of Revenue 9.0M 7.6M 5.0M 4.0M
Gross Profit 47.6M 55.5M 56.5M 56.0M
Selling General And Administration 26.9M 28.3M 29.9M 26.4M
General And Administrative Expense 10.2M 8.4M 12.0M 11.7M
Depreciation And Amortization In Income Statement 22.7M 31.9M 34.4M 30.3M
Other Operating Expenses 5.7M 5.6M 5.7M 5.7M
Operating Expense 55.3M 65.8M 70.0M 62.3M
Operating Income -7.7M -10.3M -13.5M -6.3M
EBIT -5.5M -19.1M -16.4M -4.9M
Interest Expense 10.1M 8.7M 7.3M 7.0M
Interest Expense Non Operating 10.1M 8.7M 7.3M 7.0M
Interest Income 319,000 350,000 57,000 44,000
Interest Income Non Operating 319,000 350,000 57,000 44,000
Net Interest Income -9.8M -8.4M -7.3M -6.9M
Other Income Expense 1.9M -9.1M -3.0M 1.4M
Other Non Operating Income Expenses 3.4M -- -- --
Special Income Charges -1.5M -7.7M -5.2M -169,000
Restructuring And Mergern Acquisition 1.5M 3.8M 2.1M 169,000
Write Off -- -- 3.1M 0.00
Gain On Sale Of Security -5,000 -1.4M 2.2M 1.6M
Pretax Income -15.6M -27.8M -23.7M -11.8M
Tax Provision 4.1M -272,000 -124,000 1.3M
Tax Effect Of Unusual Items -226,950 -88,596 -15,499 367,820
Net Income From Continuing And Discontinued Operation -19.7M -27.5M -23.6M -13.1M
Net Income From Continuing Operation Net Minority Interest -19.7M -27.5M -23.6M -13.1M
Net Income Including Noncontrolling Interests -19.7M -27.5M -23.6M -13.1M
Net Income Common Stockholders -19.7M -27.5M -23.6M -13.1M
Net Income -19.7M -27.5M -23.6M -13.1M
EBITDA 17.2M 12.9M 18.0M 25.4M
Normalized EBITDA 18.7M 21.9M 21.0M 24.0M
Reconciled Depreciation 22.7M 31.9M 34.4M 30.3M
Basic EPS -0.62 -0.85 -0.73 -0.41
Diluted EPS -0.62 -0.85 -0.73 -0.41
Basic Average Shares 31.8M 32.3M 32.4M 32.2M
Diluted Average Shares 31.8M 32.3M 32.4M 32.2M
Total Unusual Items -1.5M -9.1M -3.0M 1.4M
Total Unusual Items Excluding Goodwill -1.5M -9.1M -3.0M 1.4M
Tax Rate For Calcs 0.15 0.01 0.01 0.27
Normalized Income -18.4M -18.6M -20.6M -14.1M
Depreciation Amortization Depletion Income Statement 22.7M 31.9M 34.4M 30.3M
Diluted NI Availto Com Stockholders -19.7M -27.5M -23.6M -13.1M
Impairment Of Capital Assets 0.00 3.9M 3.1M 0.00
Net Income Continuous Operations -19.7M -27.5M -23.6M -13.1M
Net Non Operating Interest Income Expense -9.8M -8.4M -7.3M -6.9M
Other Gand A 8.6M 8.9M 9.1M 9.4M
Reconciled Cost Of Revenue 9.0M 7.6M 5.0M 4.0M
Salaries And Wages 1.6M -538,000 2.9M 2.4M
Selling And Marketing Expense 16.7M 19.9M 17.8M 14.7M
Total Expenses 64.3M 73.4M 75.0M 66.3M
Total Operating Income As Reported -- -- -- -6.3M
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 17.5M 22.0M 20.7M 21.2M
Cash Cash Equivalents And Short Term Investments 17.5M 22.0M 20.7M 21.2M
Cash Financial 17.5M 22.0M 20.7M 21.2M
Accounts Receivable 6.7M 9.6M 8.9M 9.8M
Receivables 7.5M 10.7M 11.2M 11.5M
Inventory 9.1M 9.5M 8.9M 8.9M
Prepaid Assets 1.4M 1.9M 2.1M 2.1M
Other Current Assets -- -- 3.6M 2.1M
Current Assets 35.4M 44.1M 44.4M 43.8M
Gross PPE 3.2M 3.1M 3.3M 3.5M
Accumulated Depreciation -2.2M -2.1M -2.1M -1.9M
Net PPE 997,000 965,000 1.1M 1.6M
Goodwill And Other Intangible Assets 122.1M 162.3M 195.0M 229.2M
Other Intangible Assets 122.1M 162.3M 195.0M 229.2M
Other Non Current Assets 528,000 619,000 668,000 714,000
Total Non Current Assets 124.5M 165.0M 197.3M 232.2M
Total Assets 159.9M 209.1M 241.7M 275.9M
Current Debt 4.8M 4.7M 13.1M 12.0M
Current Debt And Capital Lease Obligation 5.3M 5.2M 13.6M 12.6M
Accounts Payable 8.7M 14.1M 11.6M 9.3M
Payables 8.9M 14.4M 12.8M 10.7M
Payables And Accrued Expenses 8.9M 14.4M 12.8M 10.7M
Other Current Liabilities 33,000 1.7M 1.9M 901,000
Current Liabilities 22.5M 26.7M 31.2M 27.7M
Long Term Debt 60.7M 82.0M 83.3M 84.1M
Long Term Debt And Capital Lease Obligation 61.2M 82.5M 83.8M 85.0M
Long Term Capital Lease Obligation 426,000 420,000 482,000 826,000
Other Non Current Liabilities 778,000 1.8M 817,000 1.9M
Total Non Current Liabilities Net Minority Interest 66.0M 84.7M 85.1M 87.5M
Total Liabilities Net Minority Interest 88.6M 111.4M 116.3M 115.2M
Common Stock 260.6M 262.1M 265.2M 265.9M
Capital Stock 260.6M 262.1M 265.2M 265.9M
Additional Paid In Capital 15.1M 13.9M 13.8M 11.7M
Retained Earnings -194.2M -175.5M -148.4M -119.9M
Gains Losses Not Affecting Retained Earnings -10.2M -2.8M -5.3M 3.0M
Other Equity Adjustments -10.2M -2.8M -5.3M 3.0M
Common Stock Equity 71.3M 97.7M 125.3M 160.7M
Stockholders Equity 71.3M 97.7M 125.3M 160.7M
Total Equity Gross Minority Interest 71.3M 97.7M 125.3M 160.7M
Total Capitalization 132.1M 179.7M 208.6M 244.9M
Net Tangible Assets -50.8M -64.6M -69.7M -68.4M
Tangible Book Value -50.8M -64.6M -69.7M -68.4M
Working Capital 12.9M 17.4M 13.2M 16.1M
Invested Capital 136.9M 184.4M 221.7M 256.9M
Total Debt 66.5M 87.6M 97.3M 97.6M
Net Debt 48.1M 64.8M 75.6M 75.0M
Share Issued 31.8M 32.0M 32.4M 32.5M
Ordinary Shares Number 31.8M 32.0M 32.4M 32.5M
Capital Lease Obligations 882,000 884,000 1.0M 1.4M
Current Capital Lease Obligation 456,000 464,000 528,000 606,000
Current Provisions 8.4M 5.4M 2.9M 3.5M
Dividends Payable -- 0.00 1.2M 1.3M
Hedging Assets Current 0.00 2,000 1.4M --
Income Tax Payable 152,000 281,000 0.00 97,000
Machinery Furniture Equipment 1.2M 1.2M 1.1M 1.1M
Non Current Deferred Assets 857,000 1.0M 465,000 690,000
Non Current Deferred Liabilities 4.1M 442,000 566,000 653,000
Non Current Deferred Taxes Assets 857,000 1.0M 465,000 690,000
Non Current Deferred Taxes Liabilities 4.1M 442,000 566,000 653,000
Non Current Prepaid Assets -- -- -- 714,000
Other Current Borrowings 4.8M 4.7M 13.1M 12.0M
Other Properties 2.0M 1.9M 2.1M 2.4M
Other Receivables 732,000 968,000 2.1M 1.7M
Taxes Receivable 71,000 86,000 195,000 0.00
Total Tax Payable 152,000 281,000 0.00 97,000
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow 8.0M 15.8M 16.9M 16.4M
Cash Flow From Continuing Operating Activities 8.0M 15.8M 16.9M 16.4M
Depreciation And Amortization 22.7M 31.9M 34.4M 30.3M
Depreciation Amortization Depletion 22.7M 31.9M 34.4M 30.3M
Stock Based Compensation 1.6M -538,000 2.9M 2.4M
Deferred Tax 3.8M -696,000 138,000 1.1M
Deferred Income Tax 3.8M -696,000 138,000 1.1M
Change In Working Capital 1.1M 5.0M 1.5M -3.0M
Changes In Account Receivables 2.4M 629,000 -71,000 1.0M
Change In Receivables 2.4M 738,000 -266,000 1.0M
Change In Inventory -189,000 -661,000 -622,000 1.8M
Change In Payables And Accrued Expense -4.4M 2.3M 3.1M -4.1M
Change In Payable -4.4M 2.3M 3.1M -4.1M
Change In Other Working Capital 2.9M 2.5M -538,000 -1.0M
Change In Other Current Assets 444,000 199,000 -169,000 -695,000
Other Non Cash Items 1.2M 797,000 810,000 783,000
Capital Expenditure -15,000 -189,000 -10.1M -4.5M
Purchase Of PPE -15,000 -41,000 -45,000 -47,000
Net PPE Purchase And Sale -15,000 -41,000 -45,000 -47,000
Purchase Of Business -1.5M 0.00 -- --
Investing Cash Flow 11.7M -189,000 -10.1M -4.5M
Cash Flow From Continuing Investing Activities 11.7M -189,000 -10.1M -4.5M
Issuance Of Debt -- 0.00 10.0M 0.00
Repayment Of Debt -21.6M -9.5M -10.4M -11.1M
Net Issuance Payments Of Debt -21.6M -9.5M -441,000 -11.1M
Repurchase Of Capital Stock -600,000 -1.6M -998,000 -47,000
Net Common Stock Issuance -600,000 -1.6M -998,000 -47,000
Common Stock Dividend Paid 0.00 -2.4M -5.0M -5.1M
Common Stock Payments -600,000 -1.6M -998,000 -47,000
Financing Cash Flow -23.4M -14.6M -6.9M -11.4M
Cash Flow From Continuing Financing Activities -23.4M -14.6M -6.9M -11.4M
Effect Of Exchange Rate Changes -870,000 268,000 -394,000 46,000
Changes In Cash -3.6M 961,000 -62,000 521,000
Beginning Cash Position 22.0M 20.7M 21.2M 20.6M
End Cash Position 17.5M 22.0M 20.7M 21.2M
Free Cash Flow 8.0M 15.6M 6.8M 11.9M
Amortization Cash Flow 22.2M 31.3M 33.7M 29.5M
Amortization Of Intangibles 22.2M 31.3M 33.7M 29.5M
Asset Impairment Charge 0.00 3.9M 3.1M 0.00
Cash Dividends Paid 0.00 -2.4M -5.0M -5.1M
Change In Account Payable -4.3M 2.0M 3.2M -3.6M
Change In Income Tax Payable -129,000 281,000 -97,000 -448,000
Change In Prepaid Assets -- -- -- 13,000
Change In Tax Payable -129,000 281,000 -97,000 -448,000
Depreciation 521,000 620,000 716,000 719,000
Gain Loss On Sale Of PPE -3.4M 0.00 -- --
Long Term Debt Issuance -- 0.00 10.0M 0.00
Long Term Debt Payments -21.6M -9.5M -10.4M -11.1M
Net Business Purchase And Sale -1.5M 0.00 -- --
Net Income From Continuing Operations -19.7M -27.5M -23.6M -13.1M
Net Intangibles Purchase And Sale 13.2M -148,000 -10.1M -4.5M
Net Long Term Debt Issuance -21.6M -9.5M -441,000 -11.1M
Net Other Financing Charges -1.2M -1.4M -639,000 --
Operating Gains Losses -3.4M -- -- --
Proceeds From Stock Option Exercised 0.00 134,000 184,000 4.9M
Purchase Of Intangibles 0.00 -148,000 -10.1M -4.5M
Sale Of Intangibles 13.2M 0.00 -- --
Unrealized Gain Loss On Investment Securities 526,000 2.9M -2.3M -2.0M
NEWS
Loading news...
TRENDING
Loading...